Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 7.09M
June 30, 2026 6.704M
March 31, 2026 6.514M
December 31, 2025 6.033M
September 30, 2025 5.795M
June 30, 2025 6.045M
March 31, 2025 6.454M
December 31, 2024 6.718M
September 30, 2024 7.068M
June 30, 2024 6.193M
March 31, 2024 5.572M
December 31, 2023 5.139M
September 30, 2023 4.492M
June 30, 2023 3.689M
March 31, 2023 2.655M
December 31, 2022 2.45M
September 30, 2022 2.41M
June 30, 2022 3.451M
March 31, 2022 3.921M
December 31, 2021 4.095M
September 30, 2021 3.945M
June 30, 2021 3.485M
March 31, 2021 3.574M
December 31, 2020 4.017M
September 30, 2020 4.244M
Date Value
June 30, 2020 4.346M
March 31, 2020 4.696M
December 31, 2019 4.661M
September 30, 2019 6.302M
June 30, 2019 8.886M
March 31, 2019 11.00M
December 31, 2018 13.14M
September 30, 2018 14.11M
June 30, 2018 14.38M
March 31, 2018 16.00M
December 31, 2017 19.41M
September 30, 2017 22.07M
June 30, 2017 22.77M
March 31, 2017 24.15M
December 31, 2016 21.40M
September 30, 2016 18.55M
June 30, 2016 19.32M
March 31, 2016 20.35M
December 31, 2015 22.49M
September 30, 2015 26.29M
June 30, 2015 26.14M
March 31, 2015 26.12M
December 31, 2014 24.52M
September 30, 2014 21.56M
June 30, 2014 22.86M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Relmada Therapeutics, Inc. 33.77M
Journey Medical Corp. 0.259M
ANI Pharmaceuticals, Inc. 50.60M
Corcept Therapeutics, Inc. 241.72M
Veru, Inc. 11.76M